Status epilepticus as a complication of SARS-CoV-2 vaccination: two case reports and systematic review with individual patients’ data analysis.

Status Epilepticus (SE) is among the most common neurological emergencies, showing a mortality rate of about 20% [1]. This condition results from a failure in seizure suppression mechanisms or the persistent activity of seizures activating networks. From an epidemiological perspective, SE has a higher incidence in children under 14, although it targets adults as well, especially those above 75 [1]. SE has the potential to impact significantly on the healthcare system due to emergency care, intensive care unit (ICU) admissions, medication expenses, and long-term rehabilitation needs.

0